Please enable JavaScript to continue using this application.

Compare $2592.HK vs $CGEM | Chartloom

Compare

$2592.HK vs $CGEM

2592.HK

Error

CGEM

Cullinan Therapeutics Inc

Compare $2592.HK vs $CGEM

2592.HK

Error

CGEMCullinan Therapeutics Inc

2592.HK

Market cap

—

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

—

52W performance

—

FCF yield

—

CGEMCullinan Therapeutics Inc

Market cap

$954M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

53.5%

52W performance

140.8%

FCF yield

-16.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

2592.HK

CGEM

Not enough overlapping price history for this window.

Detailed metrics comparison

2592.HK

CGEM

Cullinan Therapeutics Inc

Market Cap

2592.HK

CGEM$954M

Enterprise Value

2592.HK

CGEM$876M

Price

2592.HK

CGEM$15.53

P/E Ratio

2592.HK

CGEMN/A

P/S Ratio

2592.HK

CGEM0.00x

EV/Sales

2592.HK

CGEM0.00x

EV/EBITDA

2592.HK

CGEM8.02x

P/B Ratio

2592.HK

CGEM3.10x

P/FCF Ratio

2592.HK

CGEMN/A

EV/FCF

2592.HK

CGEM-5.50x

PEG Ratio

2592.HK

CGEMN/A

Forward P/E (NTM)

2592.HK

CGEMN/A

Forward P/S (NTM)

2592.HK

CGEMN/A

Revenue (TTM)

2592.HK

CGEM$0

Revenue Growth (YoY)

2592.HK

CGEMN/A

Forward Rev Growth

2592.HK

CGEM244.6%

Gross Margin (TTM)

2592.HK

CGEM0.0%

Operating Margin (TTM)

2592.HK

CGEM0.0%

EBITDA Margin (TTM)

2592.HK

CGEM0.0%

Net Margin (TTM)

2592.HK

CGEM0.0%

FCF Margin (TTM)

2592.HK

CGEMN/A

Net Income (TTM)

2592.HK

CGEM$-205M

FCF (TTM)

2592.HK

CGEM$-159M

EPS (TTM)

2592.HK

CGEM-$3.33

ROE (TTM)

2592.HK

CGEM-5289.0%

ROA (TTM)

2592.HK

CGEM-4818.0%

ROIC (TTM)

2592.HK

CGEM-5289.0%

Cash

2592.HK

CGEM$79M

Debt

2592.HK

CGEM$0

Net Cash/Debt

2592.HK

CGEM$79M

Current Ratio (TTM)

2592.HK

CGEM8.42x

Quick Ratio (TTM)

2592.HK

CGEM8.23x

Debt/Equity (TTM)

2592.HK

CGEM0.00x

Debt/Assets (TTM)

2592.HK

CGEM0.0%

Interest Coverage (TTM)

2592.HK

CGEMN/A

Net Debt/EBITDA (TTM)

2592.HK

CGEM0.00x

Beta

2592.HK

CGEM-0.03

52W Performance

2592.HK

CGEM140.8%

YTD Performance

2592.HK

CGEM53.5%

% from 52W High

2592.HK

CGEM-33.0%

% from 52W Low

2592.HK

CGEM138.9%

Asset Turnover (TTM)

2592.HK

CGEM0.00x

FCF Yield (TTM)

2592.HK

CGEM-16.7%

Earnings Yield (TTM)

2592.HK

CGEM-21.4%

Dividend Yield (TTM)

2592.HK

CGEMN/A

Rule of 40

2592.HK

CGEM0.0

EV/GP/RG

2592.HK

CGEMN/A

Ticker research

View 2592.HK research View CGEM research

Metric	2592.HK	CGEM Cullinan Therapeutics Inc
Market & Valuation
Market Cap		$954M
Enterprise Value		$876M
Price		$15.53
P/E Ratio		N/A
P/S Ratio		0.00x
EV/Sales		0.00x
EV/EBITDA		8.02x
P/B Ratio		3.10x
P/FCF Ratio		N/A
EV/FCF		-5.50x
PEG Ratio		N/A
Forward P/E (NTM)		N/A
Forward P/S (NTM)		N/A
Revenue & Growth
Revenue (TTM)		$0
Revenue Growth (YoY)		N/A
Forward Rev Growth		244.6%
Profitability
Gross Margin (TTM)		0.0%
Operating Margin (TTM)		0.0%
EBITDA Margin (TTM)		0.0%
Net Margin (TTM)		0.0%
FCF Margin (TTM)		N/A
Net Income (TTM)		$-205M
FCF (TTM)		$-159M
EPS (TTM)		-$3.33
ROE (TTM)		-5289.0%
ROA (TTM)		-4818.0%
ROIC (TTM)		-5289.0%
Financial Health
Cash		$79M
Debt		$0
Net Cash/Debt		$79M
Current Ratio (TTM)		8.42x
Quick Ratio (TTM)		8.23x
Debt/Equity (TTM)		0.00x
Debt/Assets (TTM)		0.0%
Interest Coverage (TTM)		N/A
Net Debt/EBITDA (TTM)		0.00x
Performance
Beta		-0.03
52W Performance		140.8%
YTD Performance		53.5%
% from 52W High		-33.0%
% from 52W Low		138.9%
Efficiency & Yields
Asset Turnover (TTM)		0.00x
FCF Yield (TTM)		-16.7%
Earnings Yield (TTM)		-21.4%
Dividend Yield (TTM)		N/A
Other
Rule of 40		0.0
EV/GP/RG		N/A
Ticker research	View 2592.HK research	View CGEM research

Valuation

Growth & revenue

Profitability & performance

Detailed metrics comparison

2592.HK

CGEM

Cullinan Therapeutics Inc

Market Cap

2592.HK

CGEM$954M

Enterprise Value

2592.HK

CGEM$876M

Price

2592.HK

CGEM$15.53

P/E Ratio

2592.HK

CGEMN/A

P/S Ratio

2592.HK

CGEM0.00x

EV/Sales

2592.HK

CGEM0.00x

EV/EBITDA

2592.HK

CGEM8.02x

P/B Ratio

2592.HK

CGEM3.10x

P/FCF Ratio

2592.HK

CGEMN/A

EV/FCF

2592.HK

CGEM-5.50x

PEG Ratio

2592.HK

CGEMN/A

Forward P/E (NTM)

2592.HK

CGEMN/A

Forward P/S (NTM)

2592.HK

CGEMN/A

Revenue (TTM)

2592.HK

CGEM$0

Revenue Growth (YoY)

2592.HK

CGEMN/A

Forward Rev Growth

2592.HK

CGEM244.6%

Gross Margin (TTM)

2592.HK

CGEM0.0%

Operating Margin (TTM)

2592.HK

CGEM0.0%

EBITDA Margin (TTM)

2592.HK

CGEM0.0%

Net Margin (TTM)

2592.HK

CGEM0.0%

FCF Margin (TTM)

2592.HK

CGEMN/A

Net Income (TTM)

2592.HK

CGEM$-205M

FCF (TTM)

2592.HK

CGEM$-159M

EPS (TTM)

2592.HK

CGEM-$3.33

ROE (TTM)

2592.HK

CGEM-5289.0%

ROA (TTM)

2592.HK

CGEM-4818.0%

ROIC (TTM)

2592.HK

CGEM-5289.0%

Cash

2592.HK

CGEM$79M

Debt

2592.HK

CGEM$0

Net Cash/Debt

2592.HK

CGEM$79M

Current Ratio (TTM)

2592.HK

CGEM8.42x

Quick Ratio (TTM)

2592.HK

CGEM8.23x

Debt/Equity (TTM)

2592.HK

CGEM0.00x

Debt/Assets (TTM)

2592.HK

CGEM0.0%

Interest Coverage (TTM)

2592.HK

CGEMN/A

Net Debt/EBITDA (TTM)

2592.HK

CGEM0.00x

Beta

2592.HK

CGEM-0.03

52W Performance

2592.HK

CGEM140.8%

YTD Performance

2592.HK

CGEM53.5%

% from 52W High

2592.HK

CGEM-33.0%

% from 52W Low

2592.HK

CGEM138.9%

Asset Turnover (TTM)

2592.HK

CGEM0.00x

FCF Yield (TTM)

2592.HK

CGEM-16.7%

Earnings Yield (TTM)

2592.HK

CGEM-21.4%

Dividend Yield (TTM)

2592.HK

CGEMN/A

Rule of 40

2592.HK

CGEM0.0

EV/GP/RG

2592.HK

CGEMN/A

Ticker research

View 2592.HK research View CGEM research

Metric	2592.HK	CGEM Cullinan Therapeutics Inc
Market & Valuation
Market Cap		$954M
Enterprise Value		$876M
Price		$15.53
P/E Ratio		N/A
P/S Ratio		0.00x
EV/Sales		0.00x
EV/EBITDA		8.02x
P/B Ratio		3.10x
P/FCF Ratio		N/A
EV/FCF		-5.50x
PEG Ratio		N/A
Forward P/E (NTM)		N/A
Forward P/S (NTM)		N/A
Revenue & Growth
Revenue (TTM)		$0
Revenue Growth (YoY)		N/A
Forward Rev Growth		244.6%
Profitability
Gross Margin (TTM)		0.0%
Operating Margin (TTM)		0.0%
EBITDA Margin (TTM)		0.0%
Net Margin (TTM)		0.0%
FCF Margin (TTM)		N/A
Net Income (TTM)		$-205M
FCF (TTM)		$-159M
EPS (TTM)		-$3.33
ROE (TTM)		-5289.0%
ROA (TTM)		-4818.0%
ROIC (TTM)		-5289.0%
Financial Health
Cash		$79M
Debt		$0
Net Cash/Debt		$79M
Current Ratio (TTM)		8.42x
Quick Ratio (TTM)		8.23x
Debt/Equity (TTM)		0.00x
Debt/Assets (TTM)		0.0%
Interest Coverage (TTM)		N/A
Net Debt/EBITDA (TTM)		0.00x
Performance
Beta		-0.03
52W Performance		140.8%
YTD Performance		53.5%
% from 52W High		-33.0%
% from 52W Low		138.9%
Efficiency & Yields
Asset Turnover (TTM)		0.00x
FCF Yield (TTM)		-16.7%
Earnings Yield (TTM)		-21.4%
Dividend Yield (TTM)		N/A
Other
Rule of 40		0.0
EV/GP/RG		N/A
Ticker research	View 2592.HK research	View CGEM research